Plasma HDL plays a pivotal role in reverse cholesterol transport RCT.

高密度脂蛋白是参与胆固醇逆向转运的主要物质。

This process, known as' reverse cholesterol transport ', is why HDL may have protective properties.

这一过程，被称为“逆向胆固醇运输，也是高密度脂蛋白(HDL)为什么可能有保护性。”

The present invention provides compositions adapted to enhance reverse cholesterol transport in mammals.

本发明提供适合于增加哺乳动物中反向胆固醇转运的组合物。

Plasma high density lipoprotein (HDL) has a number of functions that may be unrelated to its role in reverse cholesterol transport.

除参与胆固醇逆向转运以外，血浆高密度脂蛋白还具有多种重要生理功能。

Recent studies revealed that the antiatherosclerotic effect of HDL was mainly attributed to its role in reverse cholesterol transport(RCT).

胆固醇逆转运（RCT）是机体排出过多胆固醇的唯一途径，也是HDL抗动脉粥样硬化的重要机制之一。

HDL receptor plays a very important role in reverse cholesterol transport, and it represents a novel therapeutic target for atherosclerosis.

高密度脂蛋白受体在胆固醇逆向运输中起重要作用，并且其可以做为动脉粥样硬化的新型治疗靶点。

Kinetic studies of HDL particles or apolipoproteins provide information on the flow of lipids and have been used to investigate reverse cholesterol transport.

HDL颗粒的或载脂蛋白的动力学研究为脂质流动提供了信息，已经被用于研究胆固醇逆向转运。

INTERNATIONAL DIABETES: We need to assess RCT (reverse cholesterol transport) in order to measure the effect of drugs on promoting RCT. What is the major challenge of the methods?

《国际糖尿病》：为检验药物在改善胆固醇逆向转运(RCT)方面的效果，我们需要对RCT进行评估，在RCT检测方法我们面临的挑战是什么？